These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6609208)

  • 1. Specific antibody synthesis in vitro. I. Technical considerations.
    Moore AL; Ershler WB; Hacker MP
    J Immunol Methods; 1984 May; 70(1):13-21. PubMed ID: 6609208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis.
    Volkman DJ; Allyn SP; Fauci AS
    J Immunol; 1982 Jul; 129(1):107-12. PubMed ID: 6177745
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
    Lum LG; Culbertson NJ
    J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory roles of T4 and T8 subsets in tetanus toxoid-induced in vitro immunoglobulin production.
    Orcutt-Thordarson N; Lum LG
    Cell Immunol; 1983 Nov; 82(1):184-95. PubMed ID: 6227396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human in vivo antigen-induced lymphoblastoid B cells are capable of cyclical antibody production in vitro.
    Brieva JA; Stevens RH
    J Immunol; 1984 Jul; 133(1):147-53. PubMed ID: 6609972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.
    Kehrl JH; Fauci AS
    J Clin Invest; 1983 Apr; 71(4):1032-40. PubMed ID: 6339558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans.
    Kishimoto S; Tomino S; Mitsuya H; Nishimura H
    Clin Immunol Immunopathol; 1982 Oct; 25(1):1-10. PubMed ID: 6217937
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
    Kiessig ST; Jahn S; Porstmann T; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired generation of spontaneous and mitogen-reactive antitetanus toxoid antibody-producing B cells following repetitive in vivo booster immunization.
    Saxon A; Tamaroff MA; Morrow C; Stevens RH
    Cell Immunol; 1981 Mar; 59(1):82-96. PubMed ID: 6971181
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitogen and antigen induced B and T cell responses of peripheral blood mononuclear cells from the harbour seal (Phoca vitulina).
    de Swart RL; Kluten RM; Huizing CJ; Vedder LJ; Reijnders PJ; Visser IK; UytdeHaag FG; Osterhaus AD
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):217-30. PubMed ID: 8236799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells.
    Brozek C; Umetsu D; Schneeberger E; Geha RS
    J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.
    Brenner MK; Munro AJ
    Clin Exp Immunol; 1981 Oct; 46(1):171-7. PubMed ID: 6978212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures].
    Jahn S; Kiessig ST; Grunow R; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria.
    Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC
    Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between immunization and circulating antigen-specific plaque-forming cells.
    Falkoff RJ; Zhu LP; Fauci AS
    Cell Immunol; 1983 Jun; 78(2):392-9. PubMed ID: 6190578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific human B-cell responses: modulation by immunoregulatory T-cell subsets.
    Peters M; Fauci AS
    Cell Immunol; 1983 Dec; 82(2):223-31. PubMed ID: 6197188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of antibody by human B cells under serum-free conditions.
    Farrant J; Newton CA; North ME; Weyman C; Brenner MK
    J Immunol Methods; 1984 Mar; 68(1-2):25-34. PubMed ID: 6608557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune capacity of the chicken bursectomized at 60 hr of incubation: effect of adherent cells on the production of immunoglobulins and specific antibodies in vitro.
    Eerola E; Granfors K; Jalkanen S; Toivanen A
    Clin Immunol Immunopathol; 1984 May; 31(2):202-11. PubMed ID: 6609038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.